Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹37 Cr₹51 Cr₹43 Cr₹29 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?

The latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA is ₹37 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹37 Cr
Mar2024₹51 Cr
Mar2023₹43 Cr
Mar2022₹29 Cr
Mar2021₹45 Cr

How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹37 Cr
-27.20
Mar2024 ₹51 Cr
19.52
Mar2023 ₹43 Cr
46.71
Mar2022 ₹29 Cr
-35.46
Mar2021 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹2,733.3 Cr 2% 23.9% 113.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹100,028.0 Cr 0.5% -7.1% -14.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

2%

23.9%

113.7%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses